OSR Health, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $315.7K | $484.1K | $381.3K | $627.7K | $1.1M | $761.3K | $915.3K | $823.0K |
| Cost of Revenue | $229.1K | $323.8K | $251.6K | $366.0K | $1.1M | $592.6K | $755.2K | $643.9K |
| Gross Profit | $86.6K | $160.3K | $129.7K | $261.7K | $32.8K | $168.7K | $160.0K | $179.1K |
| Gross Margin | 27.4% | 33.1% | 34.0% | 41.7% | 2.9% | 22.2% | 17.5% | 21.8% |
| Operating Expenses | ||||||||
| Research & Development | — | $113.2K | — | — | — | $90.1K | — | — |
| SG&A Expense | $3.1M | $3.8M | $6.5M | $4.1M | $5.3M | $3.1M | $1.8M | $3.7M |
| Operating Income | $-3.0M | $-3.7M | $-6.4M | $-3.8M | $-5.2M | $-2.9M | $-1.6M | $-3.6M |
| Operating Margin | -960.8% | -757.6% | -1,674.8% | -605.9% | -460.5% | -383.3% | -176.2% | -433.4% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-1.4M | $-3.9M | $-7.8M | $-4.5M | $-5.2M | $-11.4M | $-1.8M | $-3.5M |
| Income Tax Expense | $-439.5K | $-452.3K | — | $-1.3M | — | — | $-450.6K | $-139.6K |
| Net Income | $-1.0M | $-3.5M | $-7.2M | $-3.2M | $-5.2M | $-11.4M | $-2.0M | $-231.0K |
| Net Margin | -318.1% | -716.3% | -1,900.4% | -508.9% | -460.2% | -1,496.6% | -220.9% | -28.1% |
| EPS (Basic) | $-0.02 | $-0.09 | $0.20 | $-0.01 | $0.00 | $-0.10 | $-0.22 | $-0.16 |
| EPS (Diluted) | — | $-0.08 | — | — | — | $-0.10 | $-0.47 | $-0.01 |
| Shares Outstanding (Basic) | 35.1M | 31.2M | 26.6M | 236.7M | 198.1M | 109.1M | 21.6M | 40.4M |
| Shares Outstanding (Diluted) | 35.1M | 34.3M | 26.6M | 236.7M | 198.1M | 109.1M | 21.6M | 40.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |